<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03476213</url>
  </required_header>
  <id_info>
    <org_study_id>201506S</org_study_id>
    <nct_id>NCT03476213</nct_id>
  </id_info>
  <brief_title>Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming</brief_title>
  <official_title>Reduction of Awareness and Dreaming During Neurosurgical Procedures Using Target- Controlled Infusion, Comparison With Manual Total Intravenous Anesthesia TIVA.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Hradec Kralove</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares manual total intravenous anesthesia (TIVA) and target-controll infusion
      (TCI) in reduction of awareness and dreaming, and the haemodynamical stability during
      operation. Half of patients will be anesthetized using manual TIVA and other half using TCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Awareness is possible in TIVA in case of technical failure or prolonged induction phase, TCI
      technology seems to prevent these events. Total of 80 patients planed for elective
      neurosurgical brain tumor resection fulfilling the inclusion criteria will be devided into
      two groups. First half will be anesthetized using TIVA with manual induction and the second
      half will be anesthetized using TCI. All patients will fulfil Modified Brice Questionnaire
      one hour after the end of operation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A will be anesthetized using TIVA, group B using TCI</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of awareness</measure>
    <time_frame>5 hours</time_frame>
    <description>consciousness during operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of haemodynamical instability</measure>
    <time_frame>5 hours</time_frame>
    <description>reduction of blood pressure by 25 %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reduction of norepinephrine dose</measure>
    <time_frame>5 hours</time_frame>
    <description>reduction in ugs during the whole operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Anesthesia Awareness</condition>
  <arm_group>
    <arm_group_label>Group TCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>induction and anesthesia will be held by using target-controll infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group TIVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>induction and anesthesia will be held by manual dosing of propofol and sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Group TCI</intervention_name>
    <description>Induction and anesthesia will be done by using Gepth model for sufentanil and Schnider effect model for propofol. Anesthetics will be aplicated using infusion pump Agilia (Fresenius Kabi). Another titration will be according to target value of entropy between 40 and 60 and surgical pleth index below 35.</description>
    <arm_group_label>Group TCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Group TIVA</intervention_name>
    <description>Induction of anesthesia will be done by titrating of propofol to the dose of 1.2 mg/kg and sufentanil 5-10 ug according to body weight, maintaining of anesthesia using continuous infusion of propofol 5 mg/ kg/hour and sufentanil 35 ug/hour to reach the target value of entropy between 40 and 60 and surgical pleth index below 35.</description>
    <arm_group_label>Group TIVA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Glasgow Coma scale 15

          -  ASA Physical Status Classification System I - III

          -  planed surgery for brain tumor to 5 hours

          -  postoperative awakening

        Exclusion Criteria:

          -  NYHA III, IV

          -  abuse of stimulating drugs, grass, alcohol dependence

          -  BMI over 40 in females and over 35 in men

          -  propofol alergie

          -  awake operations

          -  postoperative arteficial ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pavel Dostal, MD, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vlasta Dostalova, MD. Ph.D.</last_name>
    <phone>+420777883571</phone>
    <email>vlasta.dostalova@fnhk.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suchy Tomas, MD</last_name>
      <phone>00420495833218</phone>
      <email>suchy@fnhk.cz</email>
    </contact>
    <contact_backup>
      <last_name>Dostal Pavel, MD, PhD</last_name>
      <phone>00420495832828</phone>
      <email>pavel.dostal@fnhk.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Hradec Kralove</investigator_affiliation>
    <investigator_full_name>Dostalova Vlasta, MD, PhD</investigator_full_name>
    <investigator_title>Dostalova Vlasta, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Anesthesia Awareness</keyword>
  <keyword>Dreaming in anesthesia</keyword>
  <keyword>Total intravenous anesthesia</keyword>
  <keyword>Target-controll infusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intraoperative Awareness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

